GB Sciences (GBLX) Stock Price, News & Analysis
Price Move History
- Daily moves over 5%
- 49 237 sessions, November 6, 2025 to November 6, 2026
- Largest daily move
- +566.7% close of April 27, 2026
- 1-year change
- -66.7% closing prices, November 6, 2025 to November 6, 2026
- 1-month change
- +0% closing prices, October 6, 2026 to November 6, 2026
Company Description
GB Sciences (OTC: GBLX) is classified in the biotechnology industry within the Healthcare sector and carries a market capitalization of $40.7K.
GBLX has declined 66.7% over the past year. The last closing price was $0.0001.
For FY2024, GB Sciences reported revenue of $0.
This page collects what Stock Titan holds for GBLX, including price data, latest news, financial highlights, and short interest trends.
Stock Performance
GB Sciences (GBLX) closed at $0.0001 on November 6, 2026. Over the past 12 months, the price has lost 66.7%.
GBLX Metrics & Rankings
Price returns through November 6, 2026. Month and year figures include the first trading day. Ranking links may use different dates.
Latest News
GB Sciences has 10 recent news articles. Of the recent coverage, 5 articles coincided with positive price movement and 4 with negative movement. Key topics include AI. View all GBLX news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
GBLX Company Profile & Sector Positioning
GB Sciences (GBLX) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the OTC.
Investors comparing GBLX often look at related companies in the same sector, including Itoco Inc (ITMC), Scorpius Holdings Inc (SCPX), Nascent Biotech Inc (NBIO), Panbela Therapeutics Inc (PBLA), and Therapeutic Sltns Intl (TSOI). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate GBLX's relative position within its industry.